Autonomix Medical Inc
NASDAQ:AMIX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Autonomix Medical Inc
NASDAQ:AMIX
|
US |
|
P
|
Puuilo Oyj
OMXH:PUUILO
|
FI |
|
Altisource Portfolio Solutions SA
NASDAQ:ASPS
|
LU |
|
CNOOC Energy Technology & Services Ltd
SSE:600968
|
CN |
|
Africa Oil Corp
TSX:AOI
|
CA |
|
Oaktree Specialty Lending Corp
NASDAQ:OCSL
|
US |
|
R
|
Resources Global Development Ltd
SGX:QSD
|
SG |
|
NN Group NV
AEX:NN
|
NL |
|
Huazhu Group Ltd
HKEX:1179
|
CN |
|
Pandox AB
STO:PNDX B
|
SE |
|
Johnson Controls International PLC
NYSE:JCI
|
IE |
|
Yihai Kerry Arawana Holdings Co Ltd
SZSE:300999
|
CN |
|
SkiStar AB
STO:SKIS B
|
SE |
|
M
|
Molan Steel Co
SAU:9553
|
SA |
Autonomix Medical Inc
Autonomix Medical Inc is a US-based company operating in industry. The company is headquartered in The Woodlands, Texas and currently employs 3 full-time employees. The company went IPO on 2024-01-29. Autonomix Medical, Inc. is a medical device company, which is focused on advancing technologies to treat diseases involving the peripheral nervous system. Its technology platform includes a catheter-based microchip sensing array that has the ability to detect and differentiate peripheral neural signals with up to 1,000 times sensitivity. The company is developing a two-fold technology that can both detect malfunctioning neural signals and ablate nerves in one simple procedure for pain management. The company is developing its technology for pancreatic cancer and pancreatitis, conditions that can cause debilitating pain and need an effective solution. Its technology constitutes a platform with the potential to address dozens of indications, including in cardiology, renal denervation, and chronic pain management across a disease spectrum. Its Autonomix catheter is equipped with a microchip that converts analog signals from the body to a digital signal that can be sent directly to a computer screen.
Autonomix Medical Inc is a US-based company operating in industry. The company is headquartered in The Woodlands, Texas and currently employs 3 full-time employees. The company went IPO on 2024-01-29. Autonomix Medical, Inc. is a medical device company, which is focused on advancing technologies to treat diseases involving the peripheral nervous system. Its technology platform includes a catheter-based microchip sensing array that has the ability to detect and differentiate peripheral neural signals with up to 1,000 times sensitivity. The company is developing a two-fold technology that can both detect malfunctioning neural signals and ablate nerves in one simple procedure for pain management. The company is developing its technology for pancreatic cancer and pancreatitis, conditions that can cause debilitating pain and need an effective solution. Its technology constitutes a platform with the potential to address dozens of indications, including in cardiology, renal denervation, and chronic pain management across a disease spectrum. Its Autonomix catheter is equipped with a microchip that converts analog signals from the body to a digital signal that can be sent directly to a computer screen.
